A human study to evaluate the improvement effectiveness of Seapolynol (Ecklonia cava extract) on postprandial glucose level in healthy subjects.

Ewha Womans University0 个研究点目标入组 36 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1) Subject who voluntarily agree to participate and signs informed consent form
•2) 20 years= Age <70 years (Ratio of men and women 1:1) 3) Fasting blood glucose><126mg>/dL
•4) Subject who comply with dietary/exercise guidlines for intervention period

•1) Continuous consumption of drug that affect glucose metabolism, inflammation, antioxidative capacity and lipid metabolism or dietary supplement or oriental medicine within 4 weeks before the first visit
•2) Consumption of anticoagulant within 4 weeks before the first visit
•3) BMI=18.5 or BMI=30
•4) Following diseases :
•? Diabetes, liver dysfunction, renal dysfunction, cardiovascular diseases (hypertension(= 140/90 mmHg), stroke, etc.), thyroid diseases
•? Mental diseases such as depression, schizophrenia, alcoholism , drug addiction
•? Wasting diseases such as malignant tumor etc., and severe muscular skeletal disease
•? asthma and allergic diseases
•5) Chronic smoker (= 20 cigarettes / day)
•6) Excessive exercise (= 10 hours / week)
•7) Subjects who controlling body weight or subjects who have changed of body weight more than 4kg within 4 weeks before the first visit
•8) Recommended Food Score > 36
•9) Subjects with hypersensitivity to test materials
•10) Participation in other human study within 4 weeks before the first visit
•11) Pregnant or lactating women
•12) Any condition that the principal investigator believes may put the subjects at undue risk

发起方